SuperworthGenerate Biomedicines shares outstanding GENB
Diluted shares outstanding, averaged over each quarter, from 2025.
- Latest quarter, to Jun 30, 2026
- 128.2M
- On a year earlier
- +288.6%
- more shares
Generate Biomedicines had 128.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 288.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 128.2M | +289% | |
| Q1 FY26 | 64.9M | +98% | |
| Q2 FY25 | 33M | n/a | |
| Q1 FY25 | 32.8M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Generate Biomedicines
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.